×
About 5,923 results

ALLMedicine™ Autoimmune Hepatitis Center

Research & Reviews  2,875 results

An update on the pharmacological management of autoimmune hepatitis.
https://doi.org/10.1080/14656566.2021.1895747
Expert Opinion on Pharmacotherapy; Chung Y, Rahim MN et. al.

Feb 24th, 2021 - Autoimmune hepatitis (AIH) is an immune mediated, inflammatory disease affecting the liver as a result of environmental triggers in susceptible individuals leading to loss of self-tolerance. The immunopathogenesis of AIH is not fully understood wh...

Drug-induced liver injury: A management position paper from the Latin American Associat...
https://doi.org/10.1016/j.aohep.2021.100321
Annals of Hepatology; Bessone F, Hernandez N et. al.

Feb 20th, 2021 - Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, acute hepatitis mimicking viral he...

The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident Memory T Cells in Autoi...
https://doi.org/10.1002/hep.31739
Hepatology (Baltimore, Md.); You Z, Li Y et. al.

Feb 8th, 2021 - The diverse inflammatory response found in the liver of patients with autoimmune hepatitis (AIH) is well established, but identification of potentially pathogenic subpopulations has proven enigmatic. We report herein that CD69+ CD103+ CD8+ TRM cel...

A two decade long study of disease progression of de novo and recurrent autoimmune hepa...
https://doi.org/10.1111/petr.13978
Pediatric Transplantation; Hadley TA, Palle SK et. al.

Feb 1st, 2021 - Recurrent autoimmune hepatitis (rAIH) occurs in patients who undergo liver transplantation (LT) for AIH and de novo AIH (dAIH) is seen in patients who are transplanted for etiologies other than AIH. Whether these are distinct diseases with a simil...

see more →

Guidelines  5 results

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
https://journals.lww.com/ajg/pages/articleviewer.aspx?year=2017&issue=01000&article=00013&type=Fulltext
The American Journal of Gastroenterology; Kwo,P.,et al

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

EASL Clinical Practice Guidelines: Autoimmune hepatitis.
https://doi.org/10.1016/j.jhep.2015.06.030
Journal of Hepatology;

Sep 5th, 2015 - EASL Clinical Practice Guidelines: Autoimmune hepatitis.|2015| ,|therapeutic use,standards,drug therapy,

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepat...
https://doi.org/10.1136/gut.2010.235259
Gut Gleeson D, Heneghan MA et. al.

Jul 15th, 2011 - Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease which, if untreated, often leads to cirrhosis, liver failure and death. Major advances were made in its management based on controlled trials performed in England and the USA in th...

Diagnosis and Management of Autoimmune Hepatitis
https://www.aasld.org/sites/default/files/guideline_documents/autoimmunehepatitis2010.pdf
Michael P. Manns

May 31st, 2010 - Autoimmune hepatitis (AIH) is a generally unresolving inflammation of the liver of unknown cause. A working model for its pathogenesis postulates that environmental triggers, a failure of immune tolerance mechanisms, and a genetic predisposition c.

Diagnosis and management of autoimmune hepatitis.
https://doi.org/10.1002/hep.23584
Hepatology (Baltimore, Md.); Manns MP, Czaja AJ et. al.

May 31st, 2010 - Diagnosis and management of autoimmune hepatitis.|2010|Manns MP,Czaja AJ,Gorham JD,Krawitt EL,Mieli-Vergani G,|blood,diagnosis,drug therapy,immunology,pathology,

see more →

Clinicaltrials.gov  2,949 results

An update on the pharmacological management of autoimmune hepatitis.
https://doi.org/10.1080/14656566.2021.1895747
Expert Opinion on Pharmacotherapy; Chung Y, Rahim MN et. al.

Feb 24th, 2021 - Autoimmune hepatitis (AIH) is an immune mediated, inflammatory disease affecting the liver as a result of environmental triggers in susceptible individuals leading to loss of self-tolerance. The immunopathogenesis of AIH is not fully understood wh...

Drug-induced liver injury: A management position paper from the Latin American Associat...
https://doi.org/10.1016/j.aohep.2021.100321
Annals of Hepatology; Bessone F, Hernandez N et. al.

Feb 20th, 2021 - Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, acute hepatitis mimicking viral he...

The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident Memory T Cells in Autoi...
https://doi.org/10.1002/hep.31739
Hepatology (Baltimore, Md.); You Z, Li Y et. al.

Feb 8th, 2021 - The diverse inflammatory response found in the liver of patients with autoimmune hepatitis (AIH) is well established, but identification of potentially pathogenic subpopulations has proven enigmatic. We report herein that CD69+ CD103+ CD8+ TRM cel...

A two decade long study of disease progression of de novo and recurrent autoimmune hepa...
https://doi.org/10.1111/petr.13978
Pediatric Transplantation; Hadley TA, Palle SK et. al.

Feb 1st, 2021 - Recurrent autoimmune hepatitis (rAIH) occurs in patients who undergo liver transplantation (LT) for AIH and de novo AIH (dAIH) is seen in patients who are transplanted for etiologies other than AIH. Whether these are distinct diseases with a simil...

Incidence of Autoimmune Hepatitis May Be Rising
https://www.medscape.com/viewarticle/945131

Feb 1st, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...

see more →

News  85 results

Incidence of Autoimmune Hepatitis May Be Rising
https://www.medscape.com/viewarticle/945131

Feb 1st, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...

Treating Liver Disease During COVID-19: New Recommendations
https://www.medscape.com/viewarticle/930411

May 13th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...

AASLD: Liver transplants should proceed despite COVID-19
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News

Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.

CymaBay Therapeutics scraps two studies of liver drug; shares plunge
https://www.reuters.com/article/us-cymabay-nash/cymabay-therapeutics-scraps-two-studies-of-liver-drug-shares-plunge-idUSKBN1XZ1MC

Nov 25th, 2019 - (Reuters) - CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients, sending its shares down over 75%. The drug developer said it had obs...

Study links hepatitis, higher mortality post liver transplant
https://www.mdedge.com/jcomjournal/article/211752/hepatology/study-links-hepatitis-higher-mortality-post-liver-transplant?channel=302
Richard Mark Kirkner

Nov 6th, 2019 - Liver transplant for the three predominant autoimmune liver diseases – primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis – has been known to have favorable outcomes overall, but little evidence comparing cholang.

see more →

Patient Education  9 results see all →